脓毒性休克恢复时间缩短与住院费用降低相关
该观察性研究基于美国一家大型学术医院的行政数据,纳入587例接受血管加压药治疗的脓毒性休克成人患者,采用线性回归估算ICU住院、机械通气、血管加压药使用各减少1天及避免新增肾脏替代治疗所对应的住院费用变化。结果显示,上述恢复指标改善均与显著的费用降低相关。
要点
- 脓毒性休克住院费用中位数为98583美元。
- ICU住院、机械通气、血管加压药各减少1天分别与费用降低15670、15284、17947美元相关。
- 避免新增肾脏替代治疗与费用降低36051美元相关。
核心结论
- 缩短器官支持时间和ICU住院时间的脓毒性休克治疗可能带来显著的费用节省。
研究设计与样本
- 观察性研究,使用美国一家大型学术医院的行政数据,纳入587例在内科ICU接受血管加压药治疗的脓毒性休克成人患者。
主要发现
- 脓毒性休克住院费用中位数为98583美元(四分位距61177至136672美元)。
- ICU住院减少1天与费用降低15670美元(四分位距15023至16317美元)相关。
- 机械通气减少1天与费用降低15284美元(四分位距13566至17002美元)相关。
- 血管加压药使用减少1天与费用降低17947美元(四分位距16344至19549美元)相关。
- 避免新增肾脏替代治疗与费用降低36051美元(四分位距22353至49750美元)相关。
临床怎么用
- 在脓毒性休克救治中,缩短ICU住院、机械通气及血管加压药使用时间可能同时改善临床结局并降低住院费用。
局限性
- 研究为单中心观察性设计,基于行政数据,未在摘要中报告回归模型的具体协变量调整情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Septic shock therapies that shorten the time to physiologic and clinical recovery may result in financial savings. However, the financial implications of improving these nonmortal outcomes are not well characterized. Therefore, we quantified hospital charges associated with four outcomes: ICU length of stay, duration of invasive mechanical ventilation, duration of vasopressor use, and new renal replacement therapy. METHODS: This was an observational study using administrative data from a large academic hospital in the United States. The analysis included adults treated with vasopressors for septic shock in a medical ICU. Linear regression modeling with ordinary least square was used to estimate the incremental hospital charges associated with 1 day of ICU length of stay, 1 day of mechanical ventilation, 1 day of vasopressor use, and new renal replacement therapy. RESULTS: The study population included 587 adults with septic shock, including 180 (30.7%) who died in the hospital. The median charge for a septic shock hospitalization was $98,583 (interquartile range [IQR], $61,177-$136,672). Decreases in ICU length of stay, mechanical ventilation duration, and vasopressor duration of 1 day were associated with charge reductions of $15,670 (IQR, $15,023-$16,317), $15,284 (IQR, $13,566-$17,002), and $17,947 (IQR, $16,344-$19,549), respectively. Avoidance of new renal replacement therapy was associated with a charge reduction of $36,051 (IQR, $22,353-$49,750). CONCLUSIONS: Septic shock therapies that reduce the duration of organ support and ICU care have the potential to lead to substantial financial savings.
引用
- Self WH, Liu D, Strayer N, et al. Charge Reductions Associated With Shorter Time to Recovery in Septic Shock. Chest. 2018. PMID: 30419234. doi:10.1016/j.chest.2018.10.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。